News

FDA clears Papzimeos to treat adult respiratory papillomatosis

The Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent ...
Just The News8h

FDA starts 'real-time reporting of adverse event data' for first time

The U.S. Food and Drug Administration has started "real-time reporting of adverse event data," according to an annoucement ...

FDA Clears OTC Glucose Monitoring System for Weight Management

System integrates glucose biosensor with an AI-driven platform to show how food, activity, stress, sleep affect the body in ...

People’s Pharmacy: Is there a way to petition the FDA to change a drug’s classification?

A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...
STAT2d

FDA says it will publish reports of adverse events tied to drugs on daily basis

The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...

Noodle Recall Update as FDA Issues Risk Warning

The FDA classifies this recall as Class II, which the agency describes as a situation "in which use of or exposure to a ...

FDA Announces Recall on Over 20,000 Cans of 7Up—Here’s What to Know

FDA recalls 7Up Zero Sugar Tropical Soda for being mislabeled full-sugar soda. The affected cans were sold in 12-packs in ...

Leading Researchers Reject FDA’s Position, Find No Evidence of Harm From 7-OH in Response From Shaman Botanicals to FDA

Shaman Botanicals has issued a formal response to the FDA’s recent warning letter on its 7-hydroxymitragynine (7-OH) products ...